This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Actelion Pharmaceuticals Ltd. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Katharina Reichenbaecher: Innovator in Pharmaceutical Chemistry
Introduction
Katharina Reichenbaecher is a notable inventor based in Riehen, Switzerland. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds.
Latest Patents
Reichenbaecher holds a patent for "Salts of isobutyric acid (1 R*, 2R*, 4R*)-2-(2-{[3-(4,7-dimethoxy-1 H-benzoimidazol-2-yl)-methyl-amino}-ethyl)-5-phenyl-bicyclo[2.2.2]oct-5-en-2-yl ester." This invention relates to crystalline salts of isobutyric acid and their use as medicaments, especially as calcium channel blockers. The patent highlights processes for the preparation of these salts and pharmaceutical compositions containing them.
Career Highlights
Katharina Reichenbaecher is associated with Actelion Pharmaceuticals Ltd., where she has been instrumental in advancing research and development in the pharmaceutical sector. Her work has contributed to the creation of innovative therapeutic solutions.
Collaborations
Reichenbaecher has collaborated with esteemed colleagues such as Stéphanie Combes and Francis Hubler, enhancing the collaborative spirit within her research environment.
Conclusion
Katharina Reichenbaecher's contributions to pharmaceutical chemistry and her innovative patents underscore her role as a leading inventor in her field. Her work continues to impact the development of new medical therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
